AORT seller files to sell 4,993 shares valued at $228,970.50

Rhea-AI Filing Summary

AORT filed a Form 144 for a proposed sale of up to 4,993 common shares, with an aggregate market value of $228,970.50. The approximate sale date is 11/13/2025, through Fidelity Brokerage Services LLC, on the NYSE.

The shares were acquired via restricted stock vesting as compensation: 2,496 shares on 11/10/2025 and 2,497 shares on 11/11/2025. In the past three months, the seller reported sales of 18,200 shares on 08/27/2025 for $801,211.32 and 2,566 shares on 11/11/2025 for $114,492.10. Shares outstanding were 47,374,939; this is a baseline figure, not the amount being offered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4993	228970.50	47374939	11/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2025	Restricted Stock Vesting	Issuer			2496	11/10/2025	Compensation
Common	11/11/2025	Restricted Stock Vesting	Issuer			2497	11/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marshall S. Stanton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	08/27/2025	18200	801211.32
Marshall S. Stanton 1655 Roberts Boulevard, NW Kennesaw GA 30144	Common	11/11/2025	2566	114492.10

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AORT’s Form 144 filing disclose?

It discloses a proposed sale of 4,993 common shares with an aggregate market value of $228,970.50, to be sold on the NYSE.

When is the AORT share sale expected under Form 144?

The filing lists an approximate sale date of 11/13/2025.

Who is the broker for the AORT Form 144 sale?

The broker is Fidelity Brokerage Services LLC (Smithfield, RI).

How were the AORT shares to be sold acquired?

They were acquired via restricted stock vesting as compensation: 2,496 shares on 11/10/2025 and 2,497 shares on 11/11/2025.

What recent AORT share sales were reported by the seller?

Reported sales include 18,200 shares on 08/27/2025 for $801,211.32 and 2,566 shares on 11/11/2025 for $114,492.10.

How many AORT shares are outstanding?

The filing lists 47,374,939 shares outstanding.

On which exchange will the AORT shares be sold?

The filing names the NYSE.